Leading the way with integrated containment and delivery solutions
The first combination product that incorporates the SmartDose® Generation I (Gen. I) drug delivery platform has been approved by the U.S. Food and Drug Administration (FDA). The SmartDose Gen. I device offers a wearable, subcutaneous injector with an integrated drug delivery system that incorporates human factors and usability testing to deliver a truly patient-centric approach to self-administration.